Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

DNLIDNLI
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in DENALI THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 4.2M shares of DNLI (DENALI THERAPEUTICS INC), worth $106.9M as of 2026-Q2. The position was decreased (-5.7% shares). DNLI represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$106.9M

Current Shares

4.2M

Total Value Change

+$85.3M

Total Shares Change

+3.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
4.2M
-5.7%
$106.9M0.0%$25.72
0
2026-Q1
Increased
4.4M
+14.9%
$84.6M0.0%$20.02
34
2025-Q4
Increased
3.8M
+77.3%
$63.3M0.0%$16.41
45
2025-Q3
Increased
2.2M
+16.0%
$31.4M0.0%$14.52
33
2025-Q2
Increased
1.9M
+11.6%
$26.1M0.0%$14.10
32
2025-Q1
Increased
1.7M
+58.1%
$22.7M0.0%$14.78
41
2024-Q4
New
1.1M
-
$21.6M0.0%$20.24
39

Other major holders of DNLI: BAILLIE GIFFORD & CO, BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used